Latest news with #DavidLarsen
Business Recorder
3 days ago
- Business
- Business Recorder
UBS hires tech bankers Larsen, Michlovich from BofA in New York
NEW YORK: UBS hired two technology investment bankers in New York from Bank of America, according to a memo seen by Reuters on Thursday. David Larsen will join the Swiss bank in September, to focus on application software, according to the memo by Laurence Braham, the global co-head of technology for UBS' investment bank. UBS agrees private credit tie-up with General Atlantic The lender also hired Rob Michlovich as a managing director focused on industrial and supply chain software, who starts in July. He previously advised BofA clients in industrials and tech. 'David and Rob collectively bring over 30 years of banking experience and have advised clients on numerous high-profile M&A and capital markets transactions,' Braham wrote. 'The software sector represents a significant global fee opportunity for the firm.'
Reuters
3 days ago
- Business
- Reuters
UBS hires tech bankers Larsen, Michlovich from BofA in New York
NEW YORK, June 5 (Reuters) - UBS (UBSG.S), opens new tab hired two technology investment bankers in New York from Bank of America, according to a memo seen by Reuters on Thursday. David Larsen will join the Swiss bank in September, to focus on application software, according to the memo by Laurence Braham, the global co-head of technology for UBS' investment bank. The lender also hired Rob Michlovich as a managing director focused on industrial and supply chain software, who starts in July. He previously advised BofA clients in industrials and tech. "David and Rob collectively bring over 30 years of banking experience and have advised clients on numerous high-profile M&A and capital markets transactions," Braham wrote. "The software sector represents a significant global fee opportunity for the firm."
Yahoo
3 days ago
- Business
- Yahoo
UBS hires tech bankers Larsen, Michlovich from BofA in New York
NEW YORK (Reuters) - UBS hired two technology investment bankers in New York from Bank of America, according to a memo seen by Reuters on Thursday. David Larsen will join the Swiss bank in September, to focus on application software, according to the memo by Laurence Braham, the global co-head of technology for UBS' investment bank. The lender also hired Rob Michlovich as a managing director focused on industrial and supply chain software, who starts in July. He previously advised BofA clients in industrials and tech. "David and Rob collectively bring over 30 years of banking experience and have advised clients on numerous high-profile M&A and capital markets transactions," Braham wrote. "The software sector represents a significant global fee opportunity for the firm." Errore nel recupero dei dati Effettua l'accesso per consultare il tuo portafoglio Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati
CNBC
7 days ago
- Business
- CNBC
This software stock can gain more than 50% after being held back by macroeconomic concerns, says BTIG
Strong software demand from medical professionals can help Doximity forge a strong path ahead despite any macroeconomic concerns, according to BTIG. The investment bank upgraded the San Francisco-based company to buy from neutral on Monday, giving the stock a 12-month price target of $80, implying nearly 54% upside from Friday's $52.09 close. Despite broader macroeconomic headwinds lingering over the biopharmaceutical sector, analyst David Larsen says demand for the Doximity's software will remain strong. "Our view is that although there is macro uncertainty with respect to the bio-pharma industry, including the risk of tariffs, ongoing drug pricing reform, the Inflation Reduction Act (IRA) and Medicare Rate pressures, we believe that demand for high-quality, precise, [software as a service] commercialization efforts will continue to rise," Larsen said. DOCS YTD mountain Doximity stock in 2025. The analyst also said the market may be overstating macroeconomic concerns, especially those tied to President Donald Trump's tariffs. "While shares of DOCS have pulled back from ~$83 to ~$52 on F2026 guidance and worries around tariffs, drug pricing reform and macro headwinds, our view is that many of these concerns are overdone. We believe that the most-favored-nation order will not be broadly implemented," the analyst said. He also pointed to stronger-than-expected fourth-quarter results in May, a strong balance sheet and innovations like Doximity's self-service portal, as examples of how the company is well positioned to ride out any headwinds ahead. Shares have slipped more than 2% so far in 2025, but have soared 88% over the past year.
Business Insider
28-05-2025
- Business
- Business Insider
TD Cowen Reaffirms Their Hold Rating on P3 Health Partners (PIII)
TD Cowen analyst Ryan Langston maintained a Hold rating on P3 Health Partners (PIII – Research Report) today and set a price target of $8.00. The company's shares closed today at $7.26. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Langston covers the Healthcare sector, focusing on stocks such as Acadia Healthcare, P3 Health Partners, and UnitedHealth. According to TipRanks, Langston has an average return of -7.8% and a 27.78% success rate on recommended stocks. In addition to TD Cowen, P3 Health Partners also received a Hold from BTIG's David Larsen in a report issued on May 19. However, on May 16, William Blair maintained a Buy rating on P3 Health Partners (NASDAQ: PIII). The company has a one-year high of $33.70 and a one-year low of $7.00. Currently, P3 Health Partners has an average volume of 13.56K.
